Symptomatic Botulism
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13900 | Equine Botulinum Neurotoxin A Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| DB13903 | Equine Botulinum Neurotoxin B Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| DB13898 | Equine Botulinum Neurotoxin C Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| DB13902 | Equine Botulinum Neurotoxin D Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| DB13897 | Equine Botulinum Neurotoxin E Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| DB13901 | Equine Botulinum Neurotoxin F Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| DB13899 | Equine Botulinum Neurotoxin G Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| Drug | Drug Name | Phase | Status | Count |
|---|